• About us
• Contact

Advertisement

Organisation › Details

Illumina (Group)

Illumina (http://www.illumina.com) is a leading developer, manufacturer, and marketer of next-generation life-science tools and integrated systems for the analysis of genetic variation and biological function. Using our proprietary technologies, we provide a comprehensive line of products and services that currently serve the sequencing, genotyping, and gene expression markets, and we expect to enter the market for molecular diagnostics. Our customers include leading genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies. Our tools provide researchers around the world with the performance, throughput, cost effectiveness, and flexibility necessary to perform the billions of genetic tests needed to extract valuable medical information from advances in genomics and proteomics. We believe this information will enable researchers to correlate genetic variation and biological function, which will enhance drug discovery and clinical research, allow diseases to be detected earlier, and permit better choices of drugs for individual patients. *

 

	Start	1998-04-01 established
	Person	Thaysen, Jacob (Illumina 202309– CEO before Agilent + Dako)
	Region	San Diego, CA
	Country	United States (USA)
	Street	9885 Towne Centre Drive
	City	92121 San Diego, CA
	Tel	+1-858-202-4566
		Address record changed: 2024-01-05
Basic data	Employees	F: 1,001 to 5,000 (2012-01-25)
	Currency	USD
	Annual sales	3,333,000,000 (revenue, total, consolidated (2018) 2018-12-31)
	Profit	782,000,000 (2018-12-31)
	Cash	1,144,000,000 (2018-12-31)
		* Document for »About Section«:
		Record changed: 2023-09-09

Advertisement

More documents for Illumina (Group)

• [1] Illumina, Inc.. (9/5/23). "Press Release: Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer". San Diego, CA....
• [2] Illumina, Inc.. (7/18/23). "Press Release: The Alliance for Genomic Discovery Announces Founding Biopharma Members – AbbVie, Amgen, AstraZeneca, Bayer, and Merck". San Diego, CA....
• [3] Illumina, Inc.. (6/11/23). "Press Release: Illumina Announces CEO Transition Plan". San Diego, CA....
• [4] Bico Group AB. (11/17/21). "Press Release: Bico Announces Appointment of Susan Tousi as New Member of the Board of Directors"....
• [5] Illumina, Inc.. (6/21/19). "News: Driving Insights Through Microbiome Profiling. Metagenomic Shotgun Sequencing Workflow Enables Accurate DNA Detection From Soil"....
• [6] Fluidigm Corporation. (5/29/19). "Press Release: Fluidigm Introduces Automated Advanta Solid Tumor NGS Library Prep Assay Using Microfluidics Technology". South San Francisco, CA....
• [7] Fluidigm Corporation. (5/29/19). "Press Release: Fluidigm Introduces Advanta RNA Fusions NGS Library Prep Assay to Accelerate Translational and Clinical Cancer Research". South San Francisco, CA....
• [8] PerkinElmer, Inc.. (4/2/19). "Press Release: PerkinElmer Genomics Introduces Physician-ordered Genetic Screening Test for Proactive Health Management". Waltham, MA....

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2024. Made in Germany.